Login
Registrieren
Passwort zurücksetzen
Veröffentlichen & Verteilen
Verlagslösungen
Vertriebslösungen
Themen
Veröffentlichungen
Zeitschriften
Bücher
Konferenzberichte
Verlage
Blog
Kontakt
Suche
EUR
USD
GBP
Deutsch
English
Deutsch
Polski
Español
Français
Italiano
Warenkorb
Home
Zeitschriften
Radiology and Oncology
Band 49 (2015): Heft 4 (December 2015)
Uneingeschränkter Zugang
Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy
Norimitsu Kasahara
Norimitsu Kasahara
,
Hisao Imai
Hisao Imai
,
Kyoichi Kaira
Kyoichi Kaira
,
Keita Mori
Keita Mori
,
Kazushige Wakuda
Kazushige Wakuda
,
Akira Ono
Akira Ono
,
Tetsuhiko Taira
Tetsuhiko Taira
,
Hirotsugu Kenmotsu
Hirotsugu Kenmotsu
,
Hideyuki Harada
Hideyuki Harada
,
Tateaki Naito
Tateaki Naito
,
Haruyasu Murakami
Haruyasu Murakami
,
Masahiro Endo
Masahiro Endo
,
Takashi Nakajima
Takashi Nakajima
,
Masanobu Yamada
Masanobu Yamada
und
Toshiaki Takahashi
Toshiaki Takahashi
| 27. Nov. 2015
Radiology and Oncology
Band 49 (2015): Heft 4 (December 2015)
Über diesen Artikel
Vorheriger Artikel
Nächster Artikel
Zusammenfassung
Referenzen
Autoren
Artikel in dieser Ausgabe
Vorschau
PDF
Zitieren
Teilen
Online veröffentlicht:
27. Nov. 2015
Seitenbereich:
409 - 415
Eingereicht:
31. Jan. 2015
Akzeptiert:
06. Juli 2015
DOI:
https://doi.org/10.1515/raon-2015-0037
Schlüsselwörter
chemoradiotherapy
,
limited-stage disease small cell lung cancer
,
overall survival
,
post-progression survival
,
progression-free survival
© 2015 Norimitsu Kasahara et al., published by De Gruyter Open
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Norimitsu Kasahara
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
Hisao Imai
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
Kyoichi Kaira
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Department of Oncology Clinical Development, Gunma University Graduate School of Medicine, Japan
Keita Mori
Clinical Trial Coordination Office, Shizuoka Cancer Center, Japan
Kazushige Wakuda
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Akira Ono
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Tetsuhiko Taira
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Hirotsugu Kenmotsu
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Hideyuki Harada
Division of Radiation Oncology, Shizuoka Cancer Center, Japan
Tateaki Naito
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Haruyasu Murakami
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Masahiro Endo
Division of Diagnostic Radiology, Shizuoka Cancer Center, Japan
Takashi Nakajima
Division of Diagnostic Pathology, Shizuoka Cancer Center, Japan
Masanobu Yamada
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
Toshiaki Takahashi
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan